Clinical Experience with Wound Biofilm and Management: A Case Series

Start Page: 
38
End Page: 
49
Author(s): 
Jennifer Hurlow, GNP, CWOCN; and Philip G. Bowler, MPhil, BSc

R was 83 years old, thin-framed and ambulatory with a history of venous stasis ulcerations for which she had been treated for several months as an outpatient. She was admitted to acute care for infection of a stasis ulcer on her left calf that measured approximately 5 cm in diameter. At the time of her admission, she was wearing a compression wrap. The wound was managed topically with a silver-containing alginate dressing. Within the first week of her hospitalization, her lower extremity edema resolved due to more prolonged supine positioning. During this transition, she became less tolerant of compression and developed an area of pressure necrosis. Compression was stopped and necrotic areas were sharp debrided and treated with collagenase ointment for enzymatic debridement and polysporin powder for antimicrobial protection (see Figure 3a).

     Over approximately the next 3 weeks, Ms. R completed her systemic antibiotics. Topical wound management cleared devitalized tissue from the wound bed and pink granular buds began to develop. However, as her ambulation increased, moisture management became an issue, leading to maceration and circumferential ulceration. Because she was unable to tolerate compression, absorptive cotton pads and elevation were added to her protocol of care.

     As the exudate increased, a thick film layer over the wound bed was noticed. This film persisted after daily pulsed lavage and reformed daily despite application of collagenase. The film could be partially removed by gently rubbing the wound with a sterile gauze pad, revealing an area of red granulation tissue at the distal edge of the ulcer (see Figure 3b). On the following day, a significant amount of sanguinous drainage was noted on the cover dressing and the film had reformed over the wound bed. A silver-containing alginate dressing was applied for two consecutive days and changed daily before performing pulsed lavage. Because the pale green film reformed each day, this strategy was discontinued.

     A silver hydrofiber dressing was used for the next 3 days. This dressing seemed to provide better absorption, leaving a healthier pink/red wound bed with clearly defined contours but further treatment decisions were compromised by this product’s limited availability (this particular product is not available on facility formulary). Hydrofiber and alginate are formally considered by regulators to be interchangeable but in vivo activity appeared distinctly different in this instance. No further study of vessel perfusion pressure was provided.

     During this period of time, exudate management was a problem. The wound bed film reoccurred daily and was physically removed as much as Ms. R was able to tolerate. Wound maceration was leading to increased ulcer size, now nearly circumferential. The most absorptive formulary product, a silver-containing alginate, had demonstrated inadequate absorption for Ms. R’s wounds. Therefore, negative pressure wound therapy was initiated in an attempt to more effectively manage exudate. Ms. R tolerated -50 mm Hg continuous suction with dressing changes on Monday, Wednesday, and Friday. This strategy was effective in promoting wound progression and all ulcers became bright red and granular. Split-thickness graft was performed for final wound closure.

     Case 3. Seventy-eight-year-old Mr. D’s medical history included congestive heart failure, enlarged prostate, hypertension, and chronic lower extremity edema that had been diagnosed as venous stasis disease based on presentation. No formal venous studies had been performed. The referring physician had attempted a procedure to remove or ligate veins but this procedure did not solve Mr. D’s problem.

References: 

1. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. TRENDS in Microbiol. 2005;13(1):34–40.
2. Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Scientific American. 1978;238(1):86–95.
3. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–193.
4. Kievit TR, Iglewski BH. Bacterial quorum sensing in pathogenic relationships. Infect Immun. 2000;68(9):4839–4849.
5. Enoch S, Harding K. Wound bed preparation: the science behind the removal of barriers to healing. WOUNDS. 2003;15(7):213–229.
6. Costerton JW. A short history of the development of the biofilm concept. In: Ghannoum M, O’Toole GA (eds). Microbial Biofilms. Washington, DC: ASM Press;2004:4–19.
7. Purevdorj-Gage LB, Stoodley P. Biofilm structure, behavior and hydrodynamics. In: Ghannoum M, O’Toole GA (eds). Microbial Biofilms. Washington, DC: ASM Press;2004:160–173.
8. Starkey M, Gray KA, Chang SI, Parsek MR. A sticky business: the extracellular polymeric substance matrix of bacterial biofilms. In: Ghannoum M, O’Toole GA (eds). Microbial Biofilms. Washington, DC: ASM Press;2004:174–191.
9. Sheffield PJ. Tissue oxygen measurements. In: Davis JC, Hunt TK (eds). Problem Wounds. The Role of Oxygen. New York, NY: Elsevier; 1988:17–51.
10. Rooke T. TcPO2 in non-invasive vascular medicine. Blood Gas News. 1998;7(2):21–23.
11. Sarkisova S, Patrauchan MA, Berglund D, Nivens DE, Franklin MJ. Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms. J Bacteriol. 2005;187(13):4327–4337.
12. Chaw KC, Manimaran M, Francis EHT. Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in Staphylococcus epidemidis biofilms. Antimicrob Agents Chemother. 2005;49(12):4853–4859.
13. Percival SL, Bowler PG. Biofilms and their potential role in wound healing. WOUNDS. 2004;16(7):234–240.
14. Roberts FA, Richardson GJ, Michalek SM. Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes. Infect Immun. 1997;65(8):3248–3254.
15. Rabehi L, Irinpoulou T, Cholley B, Haeffner-Cavaillon N, Carreno M-P. Gram-positive and Gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways. Infect Immun. 2001;69(7):4590–4599.
16. Wolcott RD, Rhoads DD, Dowd SE. Biofilms and chronic wound inflammation. J Wound Care. 2008;17:333–341.
17. Cappelli G, Tetta C, Canaud B. Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating work hypothesis. Nephrol Dialysis Transplant. 2005;20:266–270.
18. Tsuneda S, Aikawa H, Hayashi H, Yuasa A, Hirata A. Extracellular polymeric substances responsible for bacterial adhesion onto solid surface. FEMS Microbiol Letters. 2003;223:287–292.
19. Lindfors J. A comparison of an antimicrobial wound cleanser to normal saline in reduction of bioburden and its effect on wound healing. Ostomy Wound Manage. 2004;50(8):28–41.
20. Shakeri S, Kermanshahi RK, Moghaddam MM. Assessment of biofilm cell removal and killing and biocide efficacy using the microtiter plate test. Biofouling. 2007;23(2):79–86.
21. Hunt TK, Hennestall RB, Pines E, et al. Impairment of microbicidal function in wounds: correction with oxygen. In: Hunt TK (ed). Soft and Hard Tissue Repair, Biological and Clinical Aspects. New York, NY: Praeger;1984:455–468.





















Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.